Adaptive metabolic changes in CADASIL white matter by Akhvlediani, Tamar et al.
ORIGINAL COMMUNICATION
Adaptive metabolic changes in CADASIL white matter
Tamar Akhvlediani Æ Anke Henning Æ
Peter S. Sa´ndor Æ Peter Boesiger Æ Hans H. Jung
Received: 9 December 2008 / Revised: 3 July 2009 / Accepted: 4 August 2009 / Published online: 19 August 2009
 Springer-Verlag 2009
Abstract Cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL) is
an important genetic cause of stroke, but pathogenic mech-
anisms and functional alterations remain poorly character-
ized. The purpose of this study was to investigate adaptive
metabolic and functional changes in white matter hyperin-
tensities and normal-appearing white matter in CADASIL
patients using 1H-magnetic resonance spectroscopic imaging
(MRSI). Eight CADASIL patients and eight matched healthy
controls were studied. 1H-MRSI data were acquired on a 3T
scanner using high-resolution multi-spin echo spectroscopic
imaging (TE = 288 ms) and non-accelerated medium-reso-
lution MRSI (TE = 35 ms). MRI of all CADASIL patients
demonstrated characteristic white matter hyper-intensities
(WMH) in the subcortical periventricular white matter.
Cre/Cho, Glx/Cho and Glx/Cre ratios were significantly
decreased in WMH compared to normal-appearing white
matter (NAWM) in patients, while Glx/Cre and mI/Cho ratios
in NAWM showed a significant increase compared to healthy
controls. In severely affected patients derived spectra reflec-
ted a decrease of NAA concentrations inside WMH when
compared to healthy white matter. Metabolic abnormalities
in WMH of CADASIL patients are compatible with axonal
loss due to chronic micro-infarctions. Increased Glx/Cre and
mI/Cho ratios in NAWM indicate an augmented glial cell
density and decreased neuronal cell density. This altered
tissue composition might be interpreted as adaptation to
hypoperfusion and impaired vasoreactivity in NAWM of
CADASIL patients. Our data might contribute to the general
understanding of adaptive processes induced by hypoperfu-
sion and chronic ischemia.
Keywords CADASIL  Magnetic resonance
spectroscopy  fMRI  MRSI
Introduction
Cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) is an
inherited cerebral small vessel disease caused by mutations
in the Notch3 gene [8, 16, 29]. Clinical manifestations
include migraine with aura, transient ischemic attacks,
recurrent strokes, psychiatric disorders, and progressive
cognitive impairment with an important variability of
clinical presentation [10, 25, 26]. CADASIL has been
recognized as the most common cause of hereditary stroke,
but probably remains still under-diagnosed [8, 9]. Diag-
nosis of CADASIL is confirmed by the presence of gran-
ular osmiophilic materials in smooth muscle cells of the
skin and muscle vessels [16, 27] or molecular genetic
analysis of the Notch3 gene [14]. Since the underlying
mechanism of CADASIL is a progressive degeneration of
the smooth muscle cells in blood vessels, an increasing
impairment of adaptive vasodilation, especially of the
small brain arteries, might be present. Indeed, previous
SPECT and PET studies have demonstrated hypoperfusion
and decreased vasoreactivity [5, 21, 23]. Hence we
hypothesize that, in addition to metabolic changes due to
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the stroke episodes and micro infarctions, the metabolism
of unaffected brain tissue might also adapt to the hypop-
erfusive state.
Cerebral T2-weighted and FLAIR MRI in CADASIL
typically shows confluent white matter signal hyper-
intensities with characteristic involvement of external
capsules and anterior temporal poles [20]. Previous proton
magnetic resonance spectroscopy studies mainly focused
on these hyper-intense white matter lesions and demon-
strated metabolic abnormalities that suggested axonal
injury, enlarged extracellular spaces, myelin loss, and gli-
osis due to microinfarctions and stroke episodes [2, 17, 19,
22]. However, results were partly inconsistent concerning
changes in normal-appearing white matter, and the patho-
genic mechanisms and the evolution of the alterations
remain poorly characterized.
The present study focused on the characterization of
differential metabolic alterations in affected and normal-
appearing white matter, possibly indicating adaptive
changes in the unaffected white matter of CADASIL
patients due to hypoperfusion, thus aiming to shed light on
disease progression and ischemic preconditioning. A
refined protocol based on medium-resolution short-echo (to
assess the spatial distribution of an enlarged number of
metabolites and to avoid misleading T2 relaxation effects)
and high-resolution long-echo (to assess the spatial distri-
bution of lactate and to achieve good correspondence of
metabolite maps and anatomical reference) proton MR
spectroscopic imaging (to compare metabolic changes in
affected and normal-appearing periventricular white matter
of CADASIL patients) was used. The investigated metabolites
were N-acetyl-aspartate (NAA)—a marker for neuronal
density and function, myo-inositol (mI)—an astro-glial
marker, glutamate plus glutamine (Glx)—markers for energy
metabolism and astro-glial neurotransmitter cycling [30],
choline containing compounds—a marker of alterations in
membrane synthesis as well as the sum of phosphocreatine
and dephosphorylated creatine (Cre)—which represent an
energy buffer system and lactate (Lac)—a marker for
increased anaerobic glycolysis [7].
Patients and methods
Patients and volunteers
We examined 8 CADASIL patients from 6 unrelated
families (3 males and 5 females; mean age 53 years, range
41–68) and 8 age and sex matched healthy volunteers
(3 males and 5 females; mean age 50 years, range 41–63).
The study was approved by the local ethics committee, and
all probands gave written informed consent. Diagnosis of
CADASIL was confirmed in all patients by skin biopsy
and/or molecular genetic analysis. The patients underwent
a structured interview and a neurological examination.
Clinical characteristics are summarized in Table 1. Four
patients had migraine with aura preceding other CADASIL
manifestations, one patient had isolated migraine auras
without headaches, and three patients had no migraine.
Four patients had sudden, transient focal neurological
disturbances without spreading, suspicious for transient
ischemic attacks, and two patients had strokes. One patient
had repetitive attacks of dizziness interpreted as vestibular
migraine. One patient had cognitive decline, depression
and a complex dyskinetic movement disorder. One patient
had a right-dominant extrapyramidal syndrome. None of
Table 1 Clinical data and genetic analysis
Case Gender Age at
examination
Notch3
mutation
Clinical features Migraine type
1 M 60 A133C Single TIA with speech arrest None
2 F 68 C174T Repetitive episodes of dizziness
Sensory aura without migraine
Aura without migraine
3 F 41 C174T Migraine with sensory and visual aura Migraine with aura
4 F 47 R184C TIA with hemihypesthesia
Migraine with sensory and visual aura
Migraine with aura
5 F 64 R169C Depression, repetitive strokes, subcortical dementia,
focal epilepsy, generalized dyskinesia,
migraine with sensory and visual aura
Migraine with aura
6 F 46 R169C TIA with brainstem symptoms
Migraine with sensory and visual aura
Migraine with aura
7 M 41 C65T Repetitive strokes with hemiparesis and aphasia None
8 M 58 R182C TIA with hemianopsia
Right-dominant rigidity
None
The skin biopsy was positive in all patients
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the patients had a stroke or migraine episode within a
month before the participation in the study. The structural
MRI images were typical for CADASIL in all patients with
confluating subcortical white matter lesions including the
anterior temporal pole.
Magnetic resonance imaging
All MR measurements were performed on a three Tesla
whole body scanner (Philips Achieva, Philips Medical
Systems, Best, The Netherlands) using a Philips transmit/
receive head coil. Subjects underwent combined brain
MRI/MRSI examination. Anatomical T2-weighted turbo
spin echo images (sagittal, coronal, transversal) were
acquired to assess the white matter lesions and to plan the
volumes of interest for MRSI.
Magnetic resonance spectroscopy
1H-MRSI data were acquired using multi spin-echo spec-
troscopic imaging (turbo spectroscopic imaging, TSI) and
unaccelerated MRSI using a sampled bandwidth of
2,500 Hz and a repetition time of 1,520 ms. Signal local-
ization was achieved by use of over-prescribed point-
resolved spectroscopy in combination with a T1 and B1
insensitive outer volume suppression scheme based on
broadband saturation pulses with polynomial phase
response [13]. Chemical shift selective spectroscopy [12]
was used for water suppression.
Long-echo time multi-spin echo spectroscopic imaging
(acceleration factor 3) enabled a high spatial resolution
(TE = 288 ms, voxel size = 8 9 8 9 15 mm) at a short
measurement time (6 min) and was used to compare
affected and normal-appearing white matter of CADASIL
patients with healthy periventricular white matter in vol-
unteers. Unaccelerated short echo-time MRSI with a
medium spatial resolution (TE = 35 ms, voxel size =
14 9 14 9 20 mm) enabled detection and evaluation of
additional metabolites, namely mI and Glx. Data were
obtained from a transversal slice aligned along the edge of
the corpus callosum and adjusted to cover occipital peri-
ventricular white matter (Fig. 1). To ensure that white
matter lesions, normal-appearing white matter or healthy
periventricular white matter would fill the entire slice
thickness at certain positions in order to avoid through-
slice partial volume effects, planning of the MRSI exami-
nation was supported by sagittal and coronal T2-weighted
scans (Fig. 1a).
The custom written software SIview (Institute for Bio-
medical Engineering, University and ETH Zurich, Swit-
zerland) was used to visualize spectra and metabolite maps.
Spectral data were post-processed using a constant baseline
Fig. 1 MRSI planning and data quality. Typical positions of the
MRSI grid (red), the MRSI slice (orange), the PRESS volume (green)
and the OVS bands (blue) (a–d) as well as averaged voxels inside
white matter lesion (black, b, c), patient NAWM (black/dotted, b, c)
and white matter in HC (white, d). In patients and healthy volunteers
MRSI slices were aligned to the corpus callosum and included as
much posterior periventricular white matter as possible (a–d). The
chosen slice thickness and position as well as selected voxel positions
inside the slice ensured that periventricular WMH and NAWM in
patients (a–c) as well as periventricular white matter in HC (d) filled
out certain voxels as completely as possible throughout the entire
slice in order to avoid partial volume effects. Typical spectral quality
of non-apodized average spectra and corresponding LC-Model fits for
short-echo time MRSI (TE = 35 ms, 2 averaged voxels each) (e) and
long-echo time TSI (TE = 288 ms, 4 averaged voxels each) (f)
demonstrate reliable quantification
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correction, B0-correction, exponential spectral filtering by
3 Hz, as well as manual zero-order and linear phase
correction.
Metabolite concentrations were estimated using LC
Model [24] from non-apodized average spectra. For the
TSI and short-echo MRSI data sets the average spectra
either contained only voxels inside WMH or the same
number of voxels inside NAWM in patients or corre-
sponding healthy white matter in controls, respectively
(Fig. 1). Selection for regions of interest in patients
depended on the location of white matter lesions inside
occipital, periventricular white matter. A voxel was con-
sidered a ‘‘WMH’’-voxel if it mainly contained hyper-
intense white matter and a ‘‘NAWM’’-voxel if it mainly
contained normal-appearing white matter with maximally
10% contributions of other tissue types. Voxel content was
inspected visually based on a T2-weighted TSE examina-
tion that had the same orientation and off-center as the
MRSI slice; the area covered by the MRSI slice was sub-
divided into five imaging slices.
Four averaged voxels were used for each tissue type for
the high-resolution TSI data sets and two averaged voxels
for the medium-resolution MRSI dataset (Fig. 1). Consid-
ering the echo times of TE = 35 ms and TE = 288 ms, two
sets of phantom spectra of 19 individual brain metabolites
each were used as a metabolite basis for fitting the LC
Model [24] to the in vivo spectra.
A widely used approach in spectroscopy is to quantify
resonance lines in terms of metabolite ratios, i.e. ratios of
intensities of particular resonance signals. This approach
corrects for many factors that otherwise influence quanti-
fication results such as B1 inhomogeneity, coil load chan-
ges and changing receive gain settings. The signal arising
from Cre is most frequently taken as an internal reference
since it remains stable during neuronal activation. Thus
NAA/Cre, mI/Cre, Glx/Cre and Cho/Cre ratios were cal-
culated from the LC Model fitting results expressed in
institutional units (IU). Due to the possible distortion of
energy metabolism in CADASIL patients, we additionally
used Cho as an internal reference, since this is stable as
long as no major structural changes occur. Thus, NAA/
Cho, mI/Cho and Glx/Cho ratios were also calculated. The
short-echo MRSI data of one subject were not quantifiable
due to pronounced movement artefacts which affected the
quality of the spectra.
Statistics
Data were analyzed for each subject individually as
described above. To account for multiple comparisons
among multiple subgroups, a repeated-measures analysis-
of-variance (repeated-measures ANOVA) was performed
comparing all metabolites and metabolite ratios between
white matter hyper-intensities (WMH), normal-appearing
white matter in patients (NAWM) and white matter in
healthy controls (HC) for the TSI data as well as for the
short-echo MRSI data sets. Subsequently, multiple uni-
variate F test based ANOVAs were performed for each
metabolite ratio to reveal their individual contributions to
the subgroup differences found in the first analysis step
(see columns labeled ‘‘ALL’’ in Tables 2, 3). Two-tailed,
paired Student’s t tests were used post hoc to compare
metabolite levels in between the subgroups. p values\0.05
were considered as statistically significant and p values
\0.1 as a statistical trend. Due to the small sample size,
normal distribution was assumed and the Student’s t test
was used in preference to parametric tests. The statistical
analysis was performed using SPSS 15.0.1. (SPPS inc.,
www.spss.com).
Results
Anatomical imaging
MRI of all CADASIL patients demonstrated characteristic
WMH in the subcortical periventricular white matter as
well as in the temporal poles. By visual inspection, the
lesions tended to be more pronounced in older patients
even if only mild clinical manifestations were present.
These changes indicate that T2 relaxation times underlie
significant changes found when comparing white matter
lesions and normal-appearing white matter of CADASIL
patients.
General group differences
Repeated-measures ANOVA analysis revealed significant
general group differences between WMH, NAWM and HC
based on the long-echo time high-resolution TSI data
(F = 1.847; p = 0.039) as well as on the short-echo time
low resolution data (F = 7.689; p = 0.007). For the TSI
data three metabolite ratios were considered, while for the
short-echo MRSI data seven metabolite ratios were inclu-
ded in this analysis (Tables 2, 3).
Table 2 Relative metabolite concentrations ± SEM from TSI data:
TE = 288 ms, voxel size = 8 9 8 9 15 mm
WMH NAWM HC ALL
NAA/Cho 10.28 ± 1.55 10.75 ± 1.91 13.474 ± 3.13 n.s.
NAA/Cre 5.06 ± 0.52 4.70 ± 0.95 4.82 ± 0.89 n.s.
Cre/Cho 2.36 ± 0.33
*p = 0.069
2.87 ± 0.55
*p = 0.069
2.96 ± 0.39 F = 3.605
p \ 0.066
Significant differences (p \ 0.05; uncorrected) between all subgroups
(last column) and between WMH and NAWM (*) are indicated
174 J Neurol (2010) 257:171–177
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Relative metabolite concentrations
Univariate ANOVA analyses performed based on results
from high-resolution long-echo TSI measurements indi-
cated general group differences between WMH, NAWM
and HC only regarding the Cre/Cho ratio (Table 2, column
‘‘ALL’’). Specifically, the Cre/Cho ratio was significantly
decreased in WMH compared to NAWM (Table 2, col-
umns ‘‘WMH’’ and ‘‘NAWM’’).
This finding was confirmed by medium-resolution short-
echo MRSI measurements. In addition, univariate ANOVA
analyses based on the short-echo MRSI data indicated
general group differences between WMH, NAWM and HC
for mI/Cho, Glx/Cho and Glx/Cre ratios (Table 3, column
‘‘ALL’’). The Glx/Cho and Glx/Cre ratios were signifi-
cantly decreased in WMH compared to NAWM. In addi-
tion, Glx/Cre ratios and mI/Cho ratios were significantly
increased in NAWM compared to HC (Table 3, columns
‘‘WMH’’, ‘‘NAWM’’ and ‘‘HC’’).
The following equations summarize the results:
Cre=Cho½ WMH\ Cre=Cho½  NAWM
Glx=Cho½ WMH\ Glx=Cho½ NAWM
Glx=Cre½ WMH\ Glx=Cre½ NAWM
Glx=Cre½ HC \ Glx=Cre½ NAWM
mI=Cho½ HC \ mI=Cho½ NAWM
ð1Þ
In CADASIL patients with extended WMH, TSI and MRSI
derived average spectra visually reflect a marked decrease of
NAA/Cre and NAA/Cho ratios inside WMH compared to
healthy white matter (Fig. 2). Group differences are only
indicative for altered NAA/Cho ratios but not statistically
significant if all patients are included in the group comparison
(Tables 1, 2). None of the CADASIL patients or volunteers
showed a marked increase in lactate sufficient to reach
detectable levels.
Discussion
The present study was designed to investigate metabolic
changes in white matter hyperintensities and normal-appear-
ing white matter in CADASIL patients using 1H-MRSI.
Decreased Cr/Cho, Glx/Cho and Glx/Cre ratios in WMH
compared to those in NAWM of CADASIL patients were
found, while there were no statistically significant differences
between WMH and HC. In addition, Glx/Cre and mI/Cho
ratios were found to be significantly increased in NAWM of
CADASIL patients if compared to healthy periventricular
white matter. In line with one previous study [19], but con-
tradicting earlier results [2, 29], no statistically significant
differences were found for mean NAA/Cho or mean NAA/Cre
ratios, neither between WMH and HC nor between WMH and
NAWM. This might be explained by substantial variations
regarding the neuronal density among the patient population.
This is supported by the exclusive observation of an unam-
biguous decrease of NAA in WMH compared to healthy
periventricular white matter in the most severely effected
elderly CADASIL patients (Fig. 2).
In accordance with histopathologic data, the observed
pattern of metabolite alterations reflects the ischemic nature
Table 3 Relative metabolite concentrations ± SEM from CSI data:
TE = 35 ms, voxel size = 14 9 14 9 20 mm
WMH NAWM HC ALL
NAA/Cho 8.37 ± 1.14 10.30 ± 0.97 9.58 ± 1.04 n.s.
Cre/Cho 3.32 ± 0.17
*p = 0.016
4.74 ± 0.39
*p = 0.016
3.74 ± 0.41 F = 4.473
p \ 0.030
mI/Cho 2.10 ± 0.22 2.66 ± 0.24
**p = 0.090
2.02 ± 0.16
**p = 0.090
F = 2.776
p \ 0.094
Glx/Cho 4.77 ± 0.70
*p = 0.094
8.17 ± 1.09
*p = 0.094
5.25 ± 0.61 F = 4.884
p \ 0.023
NAA/Cre 2.46 ± 0.30 2.13 ± 0.07 2.57 ± 1.34 n.s
mI/Cre 0.63 ± 0.06 0.56 ± 0.03 0.55 ± 0.04 n.s
Glx/Cre 1.42 ± 0.15
*p = 0.001
1.73 ± 0.18
*p = 0.001
**p = 0.0001
1.39 ± 0.08
**p = 0.0001
F = 23.543
p \ 0.0001
Significant differences (p \ 0.05; uncorrected) and trends (p \ 0.1;
uncorrected) between all subgroups (last column) and WMH and
NAWM (*), or NAWM and HC (**) are indicated
Fig. 2 NAA reduction in CADASIL white matter. Average spectra
from white matter of an HC (a) as well as of a CADASIL patient with
extended WMH (b) from corresponding TSI (TE = 288 ms) and
MRSI (TE = 35 ms) data sets. The positions of the averaged voxels
for the medium-resolution MRSI (2 averaged voxels each) and the
high-resolution TSI (4 averaged voxels each) are indicated in Fig. 1b–
d. CADASIL patients with extended WMH (b) showed a marked
NAA/Cre and NAA/Cho ratio reduction (arrow sizes are derived from
WMH) compared to healthy controls (a)
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of WMH in CADASIL [4, 11, 15, 28]. Since there was no
substantial lactate increase, we have no spectroscopic evi-
dence for acute ischemia in the patients examined. The
decrease of NAA in severely affected patients indicates a
chronic axonal loss. In addition, a slight increase of mem-
brane turnover and a distortion of the energy metabolism are
indicated by decreased mean Cre/Cho and Glx/Cho ratios in
WMH. Hence, our results suggest a slowly progressive pro-
cess due to repetitive micro-infarctions.
In contrast to WMH, NAWM of CADASIL patients
shows an increase in Glx/Cre and mI/Cho ratios compared
to healthy periventricular white matter. These findings are
not compatible with chronic or acute ischemia and might,
rather, reflect an increased astroglial cell density and a
decreased neuronal cell density compared to controls [1, 3].
In accordance with our findings, a reduction of the frac-
tional anisotropy in NAWM was measured by diffusion
weighted MR imaging [6]. Although the present study is
limited by the lack of absolute quantification and the small
sample size, the proposed alterations in neuronal and glial
cell numbers might represent a long-term adaptation of
NAWM to hypoperfusion and impaired vasoreactivity and,
more specifically, to impaired adaptive vasodilatation of
the small brain arteries during increased neuronal activa-
tion. Hypoperfusion and decreased vasoreactivity have
been demonstrated before using SPECT and PET, thus
supporting this interpretation [5, 18, 21].
In summary, metabolic abnormalities in WMH of
CADASIL patients are compatible with axonal loss due to
chronic micro-infarctions, thus being in line with previous
histopathological and MRS studies. Moreover, increased
Glx/Cre and mI/Cho ratios in NAWM indicate an aug-
mented glial cell density and decreased neuronal cell
density. This altered tissue composition might be inter-
preted as adaptation to hypoperfusion and impaired va-
soreactivity in NAWM of CADASIL patients. Therefore,
our data demonstrate differential metabolic and functional
alterations in WMH and NAWM of CADASIL brains,
which might give insight into adaptive processes of chronic
ischemia in general.
Acknowledgments T.A. received a fellowship of the European
Neurological Society (ENS). The study was supported by the
CADASIL Foundation of America. We thank Thomas Lange and
Ulrike Dydak for providing SIview and their advice on the protocol
optimization for the lactate detection and the Department of Statistics,
Faculty of Medicine, University of Zurich, for statistical support.
Conflicts of interest statement None.
References
1. Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ,
Sappey-Marinier D (2001) Regional differences and metabolic
changes in normal aging of the human brain: proton MR spec-
troscopic imaging study. Am J Neuroradiol 22:119–127
2. Auer DP, Schirmer T, Heidenreich JO, Herzog J, Puetz B,
Dichgans M (2001) Altered white, grey matter metabolism in
CADASIL: a proton MR spectroscopy and 1H-MRSI study.
Neurology 56:635–642
3. Barkhof F, van Walderveen M (1999) Characterization of tissue
damage in multiple sclerosis by nuclear magnetic resonance.
Philos Trans R Soc Lond B Biol Sci 354:1675–1686
4. Brooks WM, Wesley MH, Kodituwakku PW, Garry PJ, Rosen-
berg GA (1997) 1H-MRS differentiates white matter hyperin-
tensities in subcortical arteriosclerotic encephalopathy from those
in normal elderly. Stroke 28:1940–1943
5. Chabriat H, Bousser MG, Pappata S (1995) Cerebral autosomal
dominant arteriopathy with subcortical infarcts and leukoen-
cephalopathy: a positron emission tomography study in two
affected family members. Stroke 26:1729–1730
6. Chabriat H, Pappata S, Poupon C, Clark CA, Vahedi K, Poupon
F, Mangin JF, Pachot-Clouard M, Jobert A, Le Bihan D, Bousser
MG (1999) Clinical severity in CADASIL related to ultrastruc-
tural damage in white matter: in vivo study with diffusion tensor
MRI. Stroke 30:2637–2643
7. De Graaf RG (2007) In vivo NMR spectroscopy—principles and
techniques, 2nd edn. Wiley, West Sussex
8. Dichgans M (2002) Cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy: phenotypic
and mutational spectrum. J Neurological Sci 203–204:77–80
9. Dichgans M (2007) Genetics of ischemic stroke. Lancet Neurol
6:149–161
10. Dichgans M, Mayer M, Uttner I, Bruening R, Mueller-Hoecker J,
Rungger G, Ebke M, Klockgether T, Gasser T (1998) The phe-
notypic spectrum of CADASIL: clinical findings in 102 cases.
Ann Neurol 44:731–739
11. Gray F, Polivka M, Viswanathan A, Baudrimont M, Bousser MG,
Chabriat H (2007) Apoptosis in cerebral autosomal-dominant
arteriopathy with subcortical infarcts and leukoencephalopathy.
J Neuropathol Exp Neurol 66:597–607
12. Haase A, Frahm J, Hanicke W, Matthaei D (1985) 1H NMR
chemical shift selective (CHESS) imaging. Phys Med Biol 30(4):
341–344
13. Henning A, Scha¨r M, Schulte RF, Wilm B, Pruessmann KP,
Boesiger P (2008) SELOVS: brain MRSI localization based on
highly selective T1- and B1-insensitive outer-volume suppression
at 3T. Magn Reson Med 59:40–51
14. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton
P, Alamowitch S, Domenga V, Ce´cillion M, Marechal E, Mac-
iazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM,
Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E
(1996) Notch3 mutations in CADASIL, a hereditary adult-onset
condition causing stroke and dementia. Nature 24:707–710
15. Jouvent E, Viswanathan A, Mangin JF, O’Sullivan M, Guichard
JP, Gschwendtner A, Cumurciuc R, Buffon F, Peters N, Pachaı¨ C,
Bousser MG, Dichgans M, Chabriat H (2007) Brain atrophy is
related to lacunar lesions and tissue microstructural changes in
CADASIL. Stroke 38:1786–1790
16. Jung HH, Bassetti C, Tournier-Lasserve E, Vahedi K, Arnaboldi
M, Arifi VB, Burgunder JM (1995) Cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy: a
clinicopathological and genetic study of a Swiss family. J Neurol
Neurosurg Psychiatry 59:138–143
17. Kemp GJ (2000) Non-invasive methods for studying brain energy
metabolism: what they show and what it means. Dev Neurosci
22:418–428
18. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A
(2005) Impaired cerebral vasoreactivity in a transgenic
mouse model of cerebral autosomal dominant arteriopathy with
176 J Neurol (2010) 257:171–177
123
subcortical infarcts and leukoencephalopathy arteriopathy. Stroke
36:1053–1058
19. Macri MA, Colonnese C, Garreffa G, Fattapposta F, Restuccia R,
Bianco F, Labruna L, Maraviglia B (2006) A chemical shift
imaging study on regional metabolite distribution in a CADASIL
family. Magn Reson Imaging 24:443–447
20. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby
AH, Powell JF (2002) Diagnostic strategies in CADASIL.
Neurology 59:1134–1138
21. Mellies JK, Ba¨umer T, Mu¨ller JA, Tournier-Lasserve E, Chabriat
H, Knobloch O, Hackelo¨er HJ, Goebel HH, Wetzig L, Haller P
(1998) SPECT study of a German CADASIL family: a phenotype
with migraine and progressive dementia only. Neurology
50:1715–1721
22. Oliveri RL, Mazzei R, Gabriele AL, Gambardella A (2001) A
novel mutation in the Notch3 gene in an Italian family with
cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy—genetic and magnetic reso-
nance spectroscopic findings. Arch Neurol 58:1418–1422
23. Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T,
Hamann GF, Dichgans M (2001) Reduced cerebrovascular CO(2)
reactivity in CADASIL: a transcranial Doppler sonography study.
Stroke 32:17–21
24. Provencher SW (1993) Estimation of metabolite concentrations
from localized in vivo proton NMR spectra. Magn Reson Med
30:672–679
25. Reddy H, De Stefano N, Mortilla M, Federico A, Matthews PM
(2002) Functional reorganization of motor cortex increases with
greater axonal injury from CADASIL. Stroke 33:502–508
26. Rubio A, Rifkin D, Powers JM, Patel U, Stewart J, Faust P,
Goldman JE, Mohr JP, Numaguchi Y, Jensen K (1997) Pheno-
typic variability of CADASIL and novel morphologic findings.
Acta Neuropathol 94:247–254
27. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M,
Tournier-Lasserve E (1994) Presence of ultrastructural arterial
lesions in muscle and skin vessels of patients with CADASIL.
Stroke 25:2291–2292
28. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP,
Vermersch P, Leys D (1995) Systemic vascular smooth muscle
cell impairment in cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy. Acta Neuropathol
89:500–512
29. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop
GM, Chabriat H, Mas JL, Cabanis EA, Baudrimont M, Maciazek
J, Bach MA, Bousser MG (1993) Cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy
maps to chromosome 19q12. Nat Genet 3:256–259
30. Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U,
Schnepf B, Boeker H, Boesiger P, Northoff G (2009) The rela-
tionship between aberrant neuronal activation in the pregenual
anterior cingulate, altered glutamatergic metabolism, and anhe-
donia in major depression. Arch Gen Psychiatry 66(5):478–486
J Neurol (2010) 257:171–177 177
123
